Literature DB >> 21292378

[Poland's syndrome in women: Therapeutic indications according to the grade. Apropos of 11 cases and review of the literature].

A Baratte1, F Bodin, D Del Pin, A Wilk, C Bruant.   

Abstract

INTRODUCTION: Correction of chest and breast abnormalities in Poland's syndrome differs among authors. The aim of this study is to discuss surgical protocols according to the grade of Poland's syndrome in women. PATIENTS AND METHODS: The authors present a series of 11 women with Poland's syndrome among which nine were operated. Several surgical techniques were used. Cosmetic results were analysed according to the treatment and grade. Median follow up is 9 years.
RESULTS: In grade I, a round breast implant seems to be the best choice. In grade II, a latissimus dorsi flap combined with a breast implant gives better results than a breast implant alone. In grade III, breast and chest reconstruction are linked. The authors present a case of costal reconstruction followed by an expansion without a latissimus flap.
CONCLUSION: Many authors recommend a latissimus flap combined with a breast implant in severe grades of Poland's syndrome. Using this flap is not always possible nor mandatory. According to soft tissue quality, expansion may be an alternative way or a temporary solution during growth.
Copyright © 2011. Published by Elsevier SAS.

Entities:  

Mesh:

Year:  2011        PMID: 21292378     DOI: 10.1016/j.anplas.2010.10.016

Source DB:  PubMed          Journal:  Ann Chir Plast Esthet        ISSN: 0294-1260            Impact factor:   0.660


  2 in total

1.  Correction of Poland's Syndrome: Case Report and Review of the Current Literature.

Authors:  Tilmann Lantzsch; Dieter Lampe; Eva J Kantelhardt
Journal:  Breast Care (Basel)       Date:  2013-05       Impact factor: 2.860

2.  Bipolar Latissimus Dorsi Transfer through a Single Incision: First Key-Step in Poland Syndrome Chest Deformity.

Authors:  William Watfa; Pietro G di Summa; Wassim Raffoul
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-08-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.